SELECT COUNTRY

VIEW ALL
AFRICA
AMERICAS
ASIA
EUROPE
OCEANIA

MEXICO: LATEST INTERVIEWS MORE INTERVIEWS

Eugenio Manzano
EXECUTIVE DIRECTOR, POCHTECA
"We believe that the successful chemical distributor of the future needs to be truly digital and Pochteca is investing heavily to be at the forefront of this trend."
Mexico
Petrochemicals & Chemicals
Julio Rubio
GENERAL MANAGER, SNF FLOERGER
"In 2023, we anticipate growing our market reach by double-digits and developing new products, which will be largely driven by the expansion of the Mexican market, as well as our focus on bolstering the paper, mining, and agriculture sector through the use of our products."
Mexico
Petrochemicals & Chemicals
Martín Toscano
CEO, EVONIK
"We need to reimagine the chemical industry in Mexico to support an existing US$40 billion market with enormous growth potential to benefit from the geographical position of the country."
Mexico
Petrochemicals & Chemicals
Francisco Rubio
CEO, KEMIKALS
"Every year, our percentage of sales of sustainable products has grown, and we expect it to grow exponentially."
Mexico
Petrochemicals & Chemicals

MEXICO: LATEST ARTICLES

Mexico
Petrochemicals & Chemicals

Industry Thoughts on Mexican Agrochemicals

April 18, 2022
Challenges and Opportunities in the Agrochemicals Sector
Mexico
Petrochemicals & Chemicals

Agrochemicals

April 14, 2022
A booming export market stimulated by technology.
Peru
Mexico
Petrochemicals & Chemicals
Chile
Brazil
Argentina
Colombia
Ecuador
Venezuela
Bolivia

Logistics Challenges in 2021

August 27, 2021
How logistics specialists are dealing with global supply chain disruptions that have no near-term solution.
MORE ARTICLES

MEXICO: RECENTLY RELEASED PUBLICATIONS

Mexico Chemicals 2023

April 05, 2023

Mexico Chemicals 2023 Chemical Week Release

March 06, 2023

Latin America Petrochemicals and Chemicals 2022 - Chemical Week Release

December 04, 2022

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENTLY PUBLISHED

United States Life Sciences 2023

In many ways, 2022 was a turning point for the US life sciences industry. After having provided a lightning-quick response to the Covid-19 pandemic, the industry gathered the lessons learned and sought a sense of normalcy to continue developing necessary drugs for patients worldwide. Yet, the geopolitical, macroeconomic, and regulatory environments all come with their set of challenges, forcing executives into increasingly complex decisions when defining their strategies.
MORE PREVIOUSLY PUBLISHED

PARTNER EVENTS

SEE ALL